000 | 01159 a2200325 4500 | ||
---|---|---|---|
005 | 20250513043641.0 | ||
264 | 0 | _c19950727 | |
008 | 199507s 0 0 eng d | ||
022 | _a0025-7125 | ||
024 | 7 |
_a10.1016/s0025-7125(16)30045-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTschida, S J | |
245 | 0 | 0 |
_aAnti-infective agents and hepatic disease. _h[electronic resource] |
260 |
_bThe Medical clinics of North America _cJul 1995 |
||
300 |
_a895-917 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAnti-Infective Agents _xpharmacokinetics |
650 | 0 | 4 |
_aChloramphenicol _xpharmacokinetics |
650 | 0 | 4 |
_aClindamycin _xpharmacokinetics |
650 | 0 | 4 | _aFluoroquinolones |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIsoniazid _xpharmacokinetics |
650 | 0 | 4 |
_aLiver Diseases _xdrug therapy |
650 | 0 | 4 | _aMetabolic Clearance Rate |
650 | 0 | 4 |
_aRifampin _xpharmacokinetics |
700 | 1 | _aVance-Bryan, K | |
700 | 1 | _aZaske, D E | |
773 | 0 |
_tThe Medical clinics of North America _gvol. 79 _gno. 4 _gp. 895-917 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0025-7125(16)30045-1 _zAvailable from publisher's website |
999 |
_c7790786 _d7790786 |